Literature DB >> 2672339

Lineage-specific requirement of c-abl function in normal hematopoiesis.

D Caracciolo1, M Valtieri, D Venturelli, C Peschle, A M Gewirtz, B Calabretta.   

Abstract

Structural abnormalities of the c-abl proto-oncogene are found in hematopoietic cells of more than 90 percent of individuals with chronic myelogenous leukemia. Therefore c-abl may be important in normal as well as malignant hematopoiesis. Normal human hematopoietic progenitor cells were exposed to three different c-abl sense or antisense oligodeoxynucleotides, and the effects on myeloid and erythroid colony formation were examined. The c-abl antisense oligodeoxynucleotides inhibited myeloid, but not erythroid, colony formation. The c-abl sense oligodeoxynucleotides and bcr sense and antisense oligodeoxynucleotides were not inhibitory in this assay. These data show that c-abl is critical in normal myelopoiesis and may explain the relatively selective expansion of leukocytes in patients with chronic myelogenous leukemia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2672339     DOI: 10.1126/science.2672339

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  18 in total

1.  Antileukemia effect of c-myc N3'-->P5' phosphoramidate antisense oligonucleotides in vivo.

Authors:  T Skorski; D Perrotti; M Nieborowska-Skorska; S Gryaznov; B Calabretta
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

2.  Stage-related proliferative activity determines c-myb functional requirements during normal human hematopoiesis.

Authors:  D Caracciolo; D Venturelli; M Valtieri; C Peschle; A M Gewirtz; B Calabretta
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

3.  Coordinate expression and proliferative role of HOXB genes in activated adult T lymphocytes.

Authors:  A Carè; U Testa; A Bassani; E Tritarelli; E Montesoro; P Samoggia; L Cianetti; C Peschle
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

4.  A homeobox gene of the Antennapedia class is required for human adult erythropoiesis.

Authors:  K Takeshita; J A Bollekens; N Hijiya; M Ratajczak; F H Ruddle; A M Gewirtz
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

Review 5.  How do normal and leukemic white blood cells egress from the bone marrow? Morphological facts and biochemical riddles.

Authors:  P E Petrides; K H Dittmann
Journal:  Blut       Date:  1990-07

6.  Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging.

Authors:  B Calabretta; R B Sims; M Valtieri; D Caracciolo; C Szczylik; D Venturelli; M Ratajczak; M Beran; A M Gewirtz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

7.  Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.

Authors:  M Wetzler; M Talpaz; R A Van Etten; C Hirsh-Ginsberg; M Beran; R Kurzrock
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

8.  Role of the KIT protooncogene in normal and malignant human hematopoiesis.

Authors:  M Z Ratajczak; S M Luger; K DeRiel; J Abrahm; B Calabretta; A M Gewirtz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

9.  Cationic lipid mediated transfer of c-abl and bcr antisense oligonucleotides to immature normal myeloid cells: uptake, biological effects and modulation of gene expression.

Authors:  T Albrecht; R Schwab; C Peschel; H J Engels; T Fischer; C Huber; W E Aulitzky
Journal:  Ann Hematol       Date:  1996-02       Impact factor: 3.673

10.  Dysregulation of catalase activity in newborn myocytes during hypoxia is mediated by c-Abl tyrosine kinase.

Authors:  E Bernadette Cabigas; Jie Liu; Archana V Boopathy; Pao Lin Che; Brian H Crawford; Gitangali Baroi; Srishti Bhutani; Ming Shen; Mary B Wagner; Michael E Davis
Journal:  J Cardiovasc Pharmacol Ther       Date:  2014-05-15       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.